These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 16933718

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Angiogenesis in relation to clinical stage, apoptosis and prognostic score in myelodysplastic syndromes.
    Lundberg LG, Hellström-Lindberg E, Kanter-Lewensohn L, Lerner R, Palmblad J.
    Leuk Res; 2006 Mar; 30(3):247-53. PubMed ID: 16099505
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [A preliminary observation of bone marrow angiogenesis in patients with myelodysplastic syndromes].
    Zou WR, Liu T, Meng WT, Yu J, Niu T.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jan; 36(1):69-71. PubMed ID: 15702784
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relation between bone marrow angiogenesis and serum levels of angiogenin in patients with myelodysplastic syndromes.
    Alexandrakis MG, Passam FH, Pappa CA, Sfiridaki K, Tsirakis G, Damilakis J, Stathopoulos EN, Kyriakou DS.
    Leuk Res; 2005 Jan; 29(1):41-6. PubMed ID: 15541473
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance of WHO classification and MDS 2000 classification in myelodysplastic syndromes].
    Akiba M, Matsuda A, Misumi M, Yagasaki F, Bessho M.
    Rinsho Ketsueki; 2001 Dec; 42(12):1162-9. PubMed ID: 11828718
    [Abstract] [Full Text] [Related]

  • 9. Increased angiogenesis in the bone marrow of HIV-positive patients with myelodysplasia.
    Patsouris E, Korkolopoulou P, Androulaki A, Douzinas E, Kosmopoulou O, Kordossis T.
    Pathology; 2003 Aug; 35(4):330-5. PubMed ID: 12959769
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
    Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R.
    Haematologica; 2006 Dec; 91(12):1596-604. PubMed ID: 17145595
    [Abstract] [Full Text] [Related]

  • 15. A study of the haematologic spectrum of myelodysplastic syndrome.
    Kini J, Khadilkar UN, Dayal JP.
    Indian J Pathol Microbiol; 2001 Jan; 44(1):9-12. PubMed ID: 12561987
    [Abstract] [Full Text] [Related]

  • 16. Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
    Hamdi W, Ogawara H, Handa H, Tsukamoto N, Nojima Y, Murakami H.
    Eur J Haematol; 2009 Mar; 82(3):201-7. PubMed ID: 19018862
    [Abstract] [Full Text] [Related]

  • 17. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 Mar; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.